Jw. Bailet et al., INHIBITION OF LYMPHOCYTE FUNCTION BY HEAD AND NECK-CARCINOMA CELL-LINE SOLUBLE FACTORS, Archives of otolaryngology, head & neck surgery, 123(8), 1997, pp. 855-862
Background: Immunosuppression in patients with head and neck cancer is
well recognized. Previous investigations have demonstrated graded imm
unosuppression that becomes more pronounced as lymphocyte activity is
measured closer to the primary neoplasm. In fresh tumors, a soluble fa
ctor has been identified that may partly account for the observed grad
ed immunosuppression. Objective: To examine the effect of soluble fact
ors produced by head and neck sqamous cell carcinoma cell lines on the
generation of lymphokine activated killer cell cytotoxicity and perip
heral blood lymphocyte proliferation induced by interleukin 2, concana
valin A, and phytohemagglutinin. Design: Conditioned supernatant fluid
s were generated in a 4-day incubation period, using 5 head and neck s
quamous cell carcinoma cell lines, and were assayed for the ability to
inhibit the generation of lymphokine activated killer cell cytotoxici
ty and naive peripheral blood lymphocyte proliferation induced by inte
rleukin 2, concanavalin A, and phytohemagglutinin. Results: All condit
ioned supernatant fluids significantly inhibited the generation of lym
phokine activated killer cell cytotoxicity relative to controls, and t
his inhibition was dose dependent. In contrast, supernatant fluids fro
m a myelogenous leukemic tumor cell line, K562, and an ovarian epithel
ial cell line, SKOV-3, failed to inhibit cytotoxicity. Supernatant flu
ids conditioned with head and neck squamous cell carcinoma cell lines
also profoundly inhibited the naive peripheral blood lymphocyte prolif
eration induced by interleukin 2, concanavalin A, and phytohemagglutin
in. Conclusions: These studies demonstrate that the cell lines of head
and neck squamous cell carcinoma produce soluble factors that inhibit
lymphocyte function. Furthermore, these experiments suggest that the
inhibition previously observed with enzymatically disaggregated fresh
tumors is due to factors produced by the tumor cells rather than by ot
her cells within the tumor matrix.